Novel immunomodulatory therapies for immunoglobulin E-mediated diseases.
Levinson
Arnold I
AI
Section of Allergy and Immunology, University of Pennsylvania School of Medicine & Philadelphia Veterans' Medical Center, Philadelphia, PA, USA. frog@mail.med.upenn.edu
D000485:Allergens / Q000627:therapeutic use*; D000818:Animals; D018925:Chemokines / Q000276:immunology; D016207:Cytokines / Q000187:drug effects / Q000276:immunology; D004195:Disease Models, Animal; D004353:Drug Evaluation, Preclinical; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000097:blood / Q000276:immunology* / Q000628:therapy*; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D007167:Immunotherapy / Q000379:methods* / Q000639:trends; D017452:Receptors, IgG / Q000276:immunology; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D018418:Th2 Cells / Q000187:drug effects / Q000276:immunology
D000485:Allergens; D018925:Chemokines; D016207:Cytokines; D017452:Receptors, IgG; D007073:Immunoglobulin E